- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01409577
Outcome of FFR-guided Intervention Strategy
November 19, 2011 updated by: Bon-Kwon Koo, Seoul National University Hospital
Clinical Outcome of Fractional Flow Reserve-guided Coronary Intervention Strategy in Koreans
The investigator will evaluate the clinical outcomes of the patients in whom the treatment strategy for their coronary stenosis were determined by fractional flow reserve measurement.
Study Overview
Status
Unknown
Conditions
Detailed Description
Inclusion criteria
- Coronary stenosis
- Successful measurement of fractional flow reserve
Clinical outcomes
- Death
- Cardiac death
- Target lesion revascularization
- Target vessel revascularization
Study Type
Observational
Enrollment (Anticipated)
1500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Ilsan, Korea, Republic of
- Recruiting
- Ilsan Paik Hospital
-
Contact:
- Joon-Hyung Do, MD, Phd
-
Seoul, Korea, Republic of, 110-744
- Recruiting
- Seoul National University Hospital
-
Contact:
- Bon-Kwon Koo, MD, PhD
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients with intermediate coronary stenosis by visual estimation
Description
Inclusion Criteria:
- Coronary stenosis
- Successful fractional flow reserve measurement
Exclusion Criteria:
- Contraindication to adenosine
- Expected life expectance < 1year
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
FFR
Patients with intermediate coronary stenosis Patients with successful fractional flow measurement Feasible > 9months clinical follow-up
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Long-term MACE
Time Frame: 5 years
|
Cardiac death, MI, target vessel revascularization, target lesion revascularization
|
5 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Short-term MACE
Time Frame: 9 months
|
Cardiac death, MI, TLR/TVR
|
9 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
March 1, 2011
Primary Completion (Anticipated)
December 1, 2011
Study Completion (Anticipated)
December 1, 2011
Study Registration Dates
First Submitted
August 2, 2011
First Submitted That Met QC Criteria
August 3, 2011
First Posted (Estimate)
August 4, 2011
Study Record Updates
Last Update Posted (Estimate)
November 22, 2011
Last Update Submitted That Met QC Criteria
November 19, 2011
Last Verified
November 1, 2011
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- H1102-032-350
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.